- Published at
- by gurufocus.com
positive
positive
SATTER MANAGEMENT CO., L.P. Buys 2, Sells 1 in 2nd Quarter
GuruFocus Article or News written by insider and the topic is about:
News for Aerpio Pharmaceuticals, Inc. (ARPO)
- Published at
- by gurufocus.com
positivepositiveTop 5 1st Quarter Trades of SATTER MANAGEMENT CO., L.P.
GuruFocus Article or News written by insider and the topic is about:- Published at
- by globenewswire.com
neutralneutralAadi Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
-FYARRO™ approved November 22, 2021 and launched February 23, 2022- -FYARRO added to NCCN® Guidelines as the only preferred therapy to treat malignant...- Published at
- by etfdailynews.com
neutralneutralAadi Bioscience (NASDAQ:AADI) Downgraded to “Hold” at Zacks Investment Research
Zacks Investment Research cut shares of Aadi Bioscience (NASDAQ:AADI) from a buy rating to a hold rating in a report issued on Tuesday, Zacks.com reports. According to Zacks, “Aadi Bioscience Inc. is a clinical-stage biopharmaceutical company. It focuses on precision therapies for genetically-defined cancers with alterations in mTOR pathway genes. Aadi Bioscience Inc., formerly known […]- Published at
- by etfdailynews.com
negativenegativeAadi Bioscience (NASDAQ:AADI) Lifted to Hold at Zacks Investment Research
Zacks Investment Research upgraded shares of Aadi Bioscience (NASDAQ:AADI) from a sell rating to a hold rating in a research report released on Wednesday morning, Zacks.com reports. According to Zacks, “Aadi Bioscience Inc. is a clinical-stage biopharmaceutical company. It focuses on precision therapies for genetically-defined cancers with alterations in mTOR pathway genes. Aadi Bioscience Inc., […]- Published at
- by gurufocus.com
mixedmixedSatter Management Co., L.p. Buys Aadi Bioscience Inc, Sells Aerpio Pharmaceuticals Inc
GuruFocus Article or News written by insider and the topic is about:- Published at
- by gurufocus.com
positivepositiveAscent Wealth Partners, LLC Buys BTC iShares Core MSCI EAFE ETF, Communication Services Select Sector SPDR Fund, T. Rowe Price Growth Stock ETF, Sells iShares Core MSCI Emerging Markets ETF, Intel Cor
GuruFocus Article or News written by insider and the topic is about:- Published at
- by marketscreener.com
positivepositiveAadi Bioscience : Amendment No.1 to the Amended and Restated License Agreement between Abraxis BioScience, LLC and Aadi Bioscience, Inc (Form 8-K)
Amendment No.1 to the Amended and Restated License Agreement between Abraxis BioScience, LLC and Aadi Bioscience, Inc. On August 30, 2021, Aadi Subsidiary, Inc.,... | September 3, 2021- Published at
- by insidermonkey.com
mixedmixedMichael Burry Is Selling These 15 Stocks
Hedge fund managers famous for their short-selling exploits have had an eventful few months, especially in the context of the rise of retail investors in the marketplace and the incredible numbers posted...ZYMEVACQWVACQUVACQUBPUBATSLAD.BATSLAC.BATSLA34.SATSLA.MXTSLATL0.DERPTRKLBPDSPD.TOIMKTAHPGBLDNOW.MXDNOW0K9J.L0J4G.LWMTD.BAWMTC.BAWMT.SNWMT.MXWMT.DEWMTWALMARTCL.SNKHNZ.DEKHC.MXKHCGOOGL.SNGOOGL.MXGOOGL.BAGOOGLGOOGCL.SNGOOG.SNGOOG.MXGOOGGOGLD.BAGNKWFGNKFBOK34.SAFBD.BAFBCL.SNFB2A.DEFB.SNFB.MXFBCVSH34.SACVSCL.SNCVS.SNCVS.MXCVS.DECVSARPOABEC.DEABEA.DE0HRS.L- Published at
- by globenewswire.com
mixedmixedAadi Bioscience Announces Closing of Merger with Aerpio Pharmaceuticals and $155M Private Placement
Shares of Aadi to commence trading on the Nasdaq Capital Market on August 27, 2021 under ticker symbol “AADI”Concurrent $155 million PIPE financing is...- Published at
- by prnewswire.com
mixedmixedLifshitz Law Firm, P.C. Announces Investigation of ARPO, BSCA, BCAL, CNBKA, DSSI, INSW, FTIV, FI, ONB, FMBI, and GRA
/PRNewswire/ -- Aerpio Pharmaceuticals, Inc. (NasdaqCM: ARPO) Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in...- Published at
- by prnewswire.com
positivepositiveQuantum Leap Healthcare Collaborative Discontinues Testing of Aerpio Pharmaceutical's Razuprotafib in I-SPY COVID Trial
/PRNewswire/ -- Quantum Leap Healthcare Collaborative (QLHC), the sponsor of the I-SPY COVID Trial, will not proceed with further testing of the Aerpio...- Published at
- by benzinga.com
positivepositiveQuantum Leap Healthcare Collaborative Discontinues Testing of Aerpio Pharmaceutical's Razuprotafib in I-SPY COVID Trial
SAN FRANCISCO and CINCINNATI, March 05, 2021 (GLOBE NEWSWIRE) -- Quantum Leap Healthcare Collaborative (QLHC), the sponsor of the I-SPY COVID Trial, will ...- Published at
- by benzinga.com
mixedmixedThe Daily Biotech Pulse: Aerpio Reviews Strategic Options, Hologic Goes Shopping
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 5) Curis, ...UTHRUTH.SGUTH.MUUTH.FUTH.BETRL.MUTRL.FTRL.BESWAVSLNS1BA.MUS1BA.FRNLXRENX.LPLSEONCRNKTRNG9.MUNG9.FNG9.BENEO.MXNEOMYGNMITOLMATLHU.SGLHU.FITH.FITH.BEILU.SGILU.MUILU.FILU.DEILU.BEILMN.MXILMNHXB2.FFDMTEYEGDVAARPOAIM7EYA.MU7EYA.F6L8.F6L8.BE36M.MU36M.F36M.BE335.MU335.F335.BE2O9.FMYD.SGMYD.MUMYD.FMYD.DEMYD.BEJNJJAGXIMABHOLXGMABGE91.MUGE91.FFLGT.MXFLGTEO7.MUEO7.FEO7.BEENDPCUSA.FCUSA.BECRIS7F0.F7F0.BE1JA2.SG1JA2.F1JA2.BE0VY.FHOLX.MXHO1.MUHO1.FHO1.DEHO1.BE- Published at
- by rttnews.com
mixedmixedPre-market Movers In Healthcare Sector: ISR, GHSI, NMTR, CHEK, BBI…
What's moving these stocks in pre-market hours today?.- Published at
- by rttnews.com
mixedmixedMRKR Soars As FDA Lifts Hold On MT-401, RYTM Sells Priority Review Voucher, MLND Dumps MLE-301
Today's Daily Dose brings you news about the FDA lifting the partial clinical hold on Marker Therapeutics' phase II post-transplant acute myeloid leukemia trial; Rhythm selling its Rare Pediatric Disease Priority Review Voucher for $100 million; Hoth Therapeutics' financing agreement; Millendo discontinuing further development of MLE-301 for the treatment of menopausal vasomotor symptoms.- Published at
- by benzinga.com
mixedmixedAerpio Announces Strategic Review after Topline Results from Razuprotafib Glaucoma Phase 2 Trial
CINCINNATI, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Aerpio Pharmaceuticals, Inc. ("Aerpio" or the "Company") (NASDAQ:ARPO), a biopharmaceutical company focused on ...